SIP 1.55% $1.31 sigma pharmaceuticals limited

appears to be strong support- emerging, page-24

  1. asf
    9,887 Posts.
    Orbis were reported in the AFR as saying they expected a capital return with a greater premium than was spoken about in the media. This caused a small spike in th SP, but it's fallen to the usual SIP fare. SIP is releasing its half year financial statements on the 29th September- this Wednesday. If there is market expectation that SIP make comment/commitment to a capital return then, we may see some kind of buying pressure early this week.
 
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.